It seems to me that the word is out about the uptake of Xtandi. This is not a window-dressing stock, since it's basically gone nowhere this year compared to other biotechs.
You think this is a dead board, try looking at the ILMN board......that stock has soared and it's like everyone is at a wake.
Me thinks prostate news next month will be very good. Hold on to your shorts.